
Frontiers in Aging Neuroscience, Год журнала: 2024, Номер 16
Опубликована: Июнь 7, 2024
Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) plays a crucial role in the pathogenesis of Alzheimer's disease (AD). This review comprehensively examines sTREM2's involvement AD, focusing its regulatory functions microglial responses, neuroinflammation, and interactions with key pathological processes. We discuss dynamic changes sTREM2 levels cerebrospinal fluid plasma throughout AD progression, highlighting potential as therapeutic target. Furthermore, we explore impact genetic variants expression interplay other risk genes. The evidence presented this suggests that modulating activity could influence trajectory, making it promising avenue for future research drug development. By providing holistic understanding multifaceted aims to guide studies inspire novel strategies.
Язык: Английский